New psychoactive substances that pose health, social and safety risks across the Union should be addressed at the Union level.
Nove psihoaktivne snovi, ki pomenijo zdravstvena, socialna in varnostna tveganja v Uniji, bi bilo treba obravnavati na ravni Unije.